"Bone Marrow Aspirate Concentrate Adjunct for Acetabular Labral Tear Re" by Seth Spicer, Hanna Brancaccio et al.
 

Document Type

Article

Version Deposited

Published Version

Publication Date

5-15-2025

Publication Title

HIP International

DOI

10.1177/11207000251337403

Abstract

BACKGROUND: The objective of this study was to determine the effect of bone marrow aspirate concentrate (BMAC) on long-term patient outcomes when used as an adjuvant to acetabular repair of the labrum.

METHODS: A systematic review and meta-analysis were completed following PRISMA 2020 guidelines. Included in the analysis were controlled studies which assessed functional outcomes via the International Hip Outcome Tool-33 (iHOT-33) 12 or 24 months after acetabular repair with BMAC adjunct. Four studies totaling 315 participants were analysed.

RESULTS: Pooled effect sizes for iHOT-33 scores were not significantly different between control and treatment groups at 12 (p = 0.14, Cohen's D ≏ 0.79) or 24 months (p = 0.30, Cohen's D ≏ 0.56).

CONCLUSIONS: Non-significant trends in favor of BMAC augmentation were found in this study. However, the trends reported are promising and warrant further investigation with further randomised controlled trials.

Creative Commons License

Creative Commons Attribution-NonCommercial 4.0 International License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Published Citation

Spicer S, Brancaccio H, Sundin A, et al. Bone marrow aspirate concentrate adjunct for acetabular labral tear repair: a systematic review and meta-analysis. HIP International. 2025;0(0). doi:10.1177/11207000251337403

Plum Print visual indicator of research metrics
PlumX Metrics
  • Usage
    • Downloads: 1
    • Abstract Views: 1
  • Captures
    • Readers: 1
  • Mentions
    • News Mentions: 1
see details

Share

COinS